Shaikh Wassi, Morris Dan, Morris Sean
From Wayne State University School of Medicine (WS), Detroit, MI; Department of Orthopedic Surgery (DM), St John Providence Health System, Southfield, MI; School of Medicine (SM), Mercer University, Macon, GA.
J Am Board Fam Med. 2016 May-Jun;29(3):404-7. doi: 10.3122/jabfm.2016.03.150242.
Chronic bisphosphonate therapy is associated with atypical fractures of the subtrochanteric and proximal femoral diaphyseal regions. Various radiologic imaging signs can identify bisphosphonate-associated stress fractures before they progress to complete fractures. Identifying patients who are at risk and modifying treatment can prevent these fractures from occurring. We present a case study of a patient taking bisphosphonate with 2 years of chronic pain, and characteristic clinical signs of bisphosphonate-associated incomplete stress fractures that went untreated until the patient suffered from a right subtrochanteric complete fracture. Our goal is to make physicians aware of the signs of insufficiency fractures associated with chronic bisphosphonate therapy such that appropriate clinical decisions are made to optimize the quality of patient care.
长期双膦酸盐治疗与股骨转子下和近端股骨干区域的非典型骨折有关。在双膦酸盐相关应力性骨折发展为完全骨折之前,各种放射学影像征象可对其进行识别。识别有风险的患者并调整治疗方案可预防这些骨折的发生。我们报告一例服用双膦酸盐的患者,其存在两年的慢性疼痛以及双膦酸盐相关不完全应力性骨折的典型临床体征,但未得到治疗,直至患者发生右侧转子下完全骨折。我们的目标是让医生了解与长期双膦酸盐治疗相关的不全骨折征象,以便做出适当的临床决策,优化患者护理质量。